Top Rule Breakers Seek Innovation
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 10 2026
0mins
Should l Buy ORCL?
Source: Fool
- Vertex Drug Trial Success: Vertex Pharmaceuticals (VRTX) rose over 5% after the closing bell due to positive trial data from Povetacicept, enhancing the likelihood of a potential accelerated FDA approval filing, which is expected to further boost the company's stock performance, surpassing a 33% increase over the S&P 500 since February 2022.
- Hewlett Packard's Strong Earnings: Hewlett Packard (HPE) gained over 1% thanks to a 380% surge in Data Center Networking sales and an upgraded group revenue forecast, indicating robust growth potential in the market that may attract more investor interest.
- Casey's and Vail Resorts Earnings Pressure: Casey's General Stores (CASY) dropped about 2% ahead of the opening bell due to only a 0.5% revenue increase, while Vail Resorts (MTN) fell after reporting a 5% quarterly revenue drop, with the CEO citing weather impacts, highlighting challenges faced by the industry.
- BioNTech Faces Losses: BioNTech (BNTX) fell over 14% ahead of the opening bell as it reported an annual net loss nearly double that of the previous year and announced plans for co-founders to create an independent company focusing on next-generation mRNA innovations, which may affect its future market performance.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ORCL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ORCL
Wall Street analysts forecast ORCL stock price to rise
34 Analyst Rating
25 Buy
9 Hold
0 Sell
Moderate Buy
Current: 139.660
Low
180.00
Averages
309.59
High
400.00
Current: 139.660
Low
180.00
Averages
309.59
High
400.00
About ORCL
Oracle Corporation offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. The Company operates through three businesses: cloud and license, hardware and service. Its cloud and license business is engaged in the sale, marketing and delivery of its enterprise applications and infrastructure technologies through cloud and on-premise deployment models including its cloud services and license support offerings, and its cloud license and on-premise license offerings. Its hardware business provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management and other hardware-related software to support diverse IT environments. Its services business provides services to customers and partners to help maximize the performance of their investments in Oracle applications and infrastructure technologies.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Class Action Initiated: Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action lawsuit against Oracle Corporation on behalf of investors who purchased securities between June 12, 2025, and December 16, 2025, indicating serious concerns over the company's financial transparency.
- False Statements Allegations: The lawsuit alleges that Oracle misled investors by promoting its AI infrastructure strategy, claiming that capital expenditures would lead to rapid revenue growth, while in reality, spending surged without corresponding revenue increases, exposing investors to significant financial risks.
- Stock Price Decline Impact: On September 24, 2025, Oracle's stock price fell by $5.37, nearly 2%, following warnings from S&P Global Ratings, highlighting market concerns about the company's future revenue dependence on OpenAI, which intensified investor anxiety.
- Funding Withdrawal: On December 17, 2025, Blue Owl Capital withdrew its funding for Oracle's $10 billion data center project, causing the stock to drop another $10.19, approximately 5.4%, reflecting a severe lack of confidence in Oracle's financial health among investors.
See More
- Lawsuit Background: Glancy Prongay Wolke & Rotter LLP reminds investors that April 6, 2026, is the deadline to file a lead plaintiff motion in the class action for those who purchased Oracle securities between June 12 and December 16, 2025, indicating potential claims for losses.
- Stock Price Volatility: On September 25, 2025, Oracle's stock fell 5.6% to $291.33 after analysts warned that future growth was overestimated, reflecting shaken market confidence in the company's AI strategy.
- Financial Shortfalls: Oracle's December 10, 2025, earnings report missed revenue and CapEx estimates, causing a 10.8% drop in stock price to $198.85, highlighting increasing financial pressures on the company.
- Funding Risks: On December 17, 2025, Oracle's primary financial backer, Blue Owl Capital, withdrew from a $10 billion data center funding, leading to a further 5.4% decline in stock price to $178.46, underscoring risks related to spending commitments and rising debt levels.
See More
- Class Action Overview: The Law Offices of Frank R. Cruz remind investors of class action lawsuits filed against BlackRock TCP Capital Corp., Oracle Corporation, Paysafe Limited, and Inovio Pharmaceuticals, urging investors to file lead plaintiff motions by the specified deadlines to protect their legal rights.
- BlackRock TCP Capital: During the period from November 6, 2024, to January 23, 2026, the lawsuit alleges that the company failed to timely and appropriately value its investments, leading to understated unrealized losses and overstated net asset value, which misled investors in their decision-making.
- Oracle Corporation: From June 12, 2025, to December 16, 2025, the lawsuit claims that Oracle's AI infrastructure strategy resulted in massive capital expenditure increases without corresponding revenue growth, heightening the company's debt risks and impacting its financial stability.
- Paysafe and Inovio: Paysafe faces allegations during the period from March 4, 2025, to November 12, 2025, for failing to disclose significant reliance on high-risk clients, potentially negatively impacting revenue growth; meanwhile, Inovio is accused of manufacturing deficiencies from October 10, 2023, to December 26, 2025, which may affect the timeliness and success of its FDA application.
See More
- Lawsuit Background: Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against Oracle Corporation and certain officers, alleging violations of federal securities laws during the period from June 12, 2025, to December 16, 2025, seeking damages for affected investors.
- Allegation Details: The complaint claims that Oracle failed to disclose that its AI infrastructure strategy would lead to significant increases in capital expenditures without corresponding near-term revenue growth, thereby heightening financial risks for the company.
- Financial Risks: Increased spending has raised serious concerns regarding Oracle's debt, credit rating, and free cash flow, potentially jeopardizing its ability to fund ongoing projects, which could lead to substantial losses for investors.
- Investor Action: Affected investors must request to be appointed as lead plaintiff by April 6, 2026, to participate in any recovery, with the law firm operating on a contingency fee basis, thus minimizing financial risk for investors.
See More
- Market Opening Outlook: The S&P 500 is set for a higher open as President Trump signals progress in U.S.-Iran war talks, reflecting investor optimism despite typically rising oil prices dragging down stocks, indicating a potential shift in market sentiment.
- S&P 500 Performance Review: The S&P 500 has faced nearly a 6% decline in March, marking its fifth consecutive weekly loss, yet it narrowly avoids entering correction territory, with upcoming job reports expected to provide insights into economic health.
- Meta Platforms Investment Advice: Morgan Stanley recommends buying Meta Platforms, asserting that sentiment has bottomed out, and despite the company facing two litigation losses last week that impacted stock prices, early trading shows a slight recovery, indicating renewed investor confidence.
- Oracle's Positive Outlook: Bernstein analysts view Oracle's cloud and database sectors as potential AI winners, setting a price target of $319, which is more than double Friday's closing price of nearly $140, reflecting strong market confidence in its growth prospects.
See More
- Surging AI Revenue: Broadcom's AI revenue exceeded $8.4 billion in the recent quarter, marking over 100% year-over-year growth, with expectations to surpass $10 billion this quarter, indicating strong customer demand for networking equipment and custom chips, thereby enhancing the company's growth potential in the AI market.
- Successful Multi-Cloud Strategy: Oracle achieved over 500% growth in multi-cloud database revenue, reflecting a rapid increase in demand for its cloud infrastructure, while its remaining performance obligations (RPO) jumped over 300% to $553 billion, showcasing the company's strong market position as businesses transition to AI applications.
- Competitive Landscape: Broadcom has successfully avoided direct competition with market leader Nvidia by offering XPUs designed for specific tasks, a differentiation strategy that has allowed it to carve out a niche in the AI accelerator market, further solidifying its market position.
- Valuation Appeal: While Broadcom is expected to grow revenue by 65% this year, Oracle's stock is trading near its lowest relative to forward earnings estimates in nearly two years, presenting an attractive investment opportunity for value-seeking investors, despite Broadcom's higher growth rate.
See More











